Sort
15,273 grants matching “antimicrobial resistance”
Procuring Native Natural Product Producers by In Situ Chimera Assembly
$240,250Robert Henry Cichewicz · University Of Oklahoma · R21 · FY2015 · AI
Admin Core - Britton
$240,242Robert A Britton · Baylor College Of Medicine · U19 · FY2023 · AI
Novel Antimicrobials: Salivary MUC7 Peptides
$240,186Libuse Anna Bobek · State University Of New York At Buffalo · R01 · FY2007 · DE
The Role of Tuberculosis Disease on Non-Communicable Disease Risk: Comparative Analysis of Large Healthcare Databases
$240,091Matthew James Magee · Emory University · R21 · FY2021 · AI
A CRISPRi screen of essential genes of Neisseria gonorrhoeae
$240,000H. Steven Seifert · Northwestern University At Chicago · R21 · FY2023 · AI
Allelic variants of Salmonella fimbrial adhesins
$240,000Dieter M. Schifferli · University Of Pennsylvania · R21 · FY2012 · AI
Microbial Genomics Biomedical Core
$240,000Anne-Catrin Uhlemann · Columbia University Health Sciences · U54 · FY2025 · DK
Bile Resistance in Pseudomonas aeruginosa
$240,000Kelly Erin Riordan Bachta · Northwestern University At Chicago · R21 · FY2025 · AI
NSF PRFB FY 2023: Does long-term selection for growth on recalcitrant vs labile carbon impact Streptomyces nutrient use or inhibitory phenotypes?
$240,000Brett Lane · Lane, Brett · · FY2023 · BIO
Orphan nuclear receptors: new mediators of defense against pore-forming toxins
$240,000Adam Jonathan Ratner · Columbia University Health Sciences · R21 · FY2014 · AI
RUI: Collaborative Research: Microbicidal Carbon Dots for Combating Anti-Biotic Resistance and Beyond
$240,000Liju Yang · North Carolina Central University · · FY2017 · MPS
Structural Biology of Gram Positive Virulence Factors
$239,923Cathleen A Earhart · University Of Minnesota · R01 · FY2008 · AI
Burkholderia pseudomallei antimicrobial resistance mechanisms
$239,888Herbert P. Schweizer · Colorado State University · U54 · FY2009 · AI
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
$239,669Brett Faine · University Of Iowa · R21 · FY2023 · AI
Membrane Active Peptides
$239,641Rice University · R01 · FY2003 · GM
Membrane Active Peptides
$239,641Rice University · R01 · FY2002 · GM
Membrane Active Peptides
$239,641Rice University · R01 · FY2004 · GM
Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need
$239,594Chang Hee Kim · Godx, Inc. · R44 · FY2020 · TR
Chemical and Biological Optimization of a Gram negative Selective Antibiotic
$239,584Jef Karel De Brabander · Ut Southwestern Medical Center · R01 · FY2016 · GM
Project 2 - Toxicant-Stimulated Disruption of Gestational Tissues with Implications for Adverse Pregnancy Outcomes
$239,552Rita Karen Loch-Caruso · Northeastern University · P42 · FY2020 · ES
Developing Non-Ototoxic Aminoglycosides
$239,466Anthony J Ricci · Stanford University · R21 · FY2012 · DC
Membrane Active Peptides
$239,454Rice University · R01 · FY2001 · GM
Targeting Glycolytic Enzymes as an Antibacterial Strategy
$239,250Dennis L Wright · University Of Connecticut Storrs · R21 · FY2018 · AI
Development of a diagnostic test for hypervirulent Klebsiella pneumoniae
$239,250Thomas A Russo · State University Of New York At Buffalo · R21 · FY2016 · AI
Interruption of Signaling-Mediated Bacterial Persistent Infections
$239,227Laurence G Rahme · Massachusetts General Hospital · R21 · FY2013 · AI